1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. AURINIA PHARMACEUTICALS INC
Aurinia Pharmaceuticals Inc XNAS: AUPH

Aurinia Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for ...

Read More
8.94 0.05 (0.56%)
71.92% Gain from 52W Low
996.6K
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Aurinia Pharmaceuticals Inc is on 01 Aug 2025 for the purpose of Aurinia Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
83.3 / 100
Valuation Score
Mid Valuation
40.0 / 100
Momentum Score
Technically Moderately Bullish
64.7 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
10
1Yr Price target upside is 12%
6 analysts

22

S

5

W

2

O

2

T

SWOT Analysis

Aurinia Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..